Видео ютуба по тегу Selumetinib

Selumetinib shrinks pediatric tumors, results of an early-phase clinical trial
Selumetinib shrinks pediatric tumors, results of an early-phase clinical trial
Jane's Koselugo (Selumetinib) Success Story
Jane's Koselugo (Selumetinib) Success Story
Pharmacology of Selumetinib for treatment of Neurofibromatosis-1 (New Drug 2020)
Pharmacology of Selumetinib for treatment of Neurofibromatosis-1 (New Drug 2020)
2021 Clinical Research Forum Top 10| Selumetinib in Children with Inoperable Plexiform Neurofibromas
2021 Clinical Research Forum Top 10| Selumetinib in Children with Inoperable Plexiform Neurofibromas
Dr Jim Whittle, presenting: Selumetinib
Dr Jim Whittle, presenting: Selumetinib
NF Summit 2022: Selumetinib - Clinical Trial Success Story
NF Summit 2022: Selumetinib - Clinical Trial Success Story
Selumetinib in children with recurrent or refractory low-grade glioma
Selumetinib in children with recurrent or refractory low-grade glioma
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Selumetinib plus dexamethasone in R/R ALL: a Phase I/II trial
Selumetinib plus dexamethasone in R/R ALL: a Phase I/II trial
Neurofibromi plessiformi: come agisce selumetinib, efficacia e sicurezza
Neurofibromi plessiformi: come agisce selumetinib, efficacia e sicurezza
Treatment for NF1 Neurofibroma
Treatment for NF1 Neurofibroma
Selumetinib in children with inoperable plexiform neurofibromas
Selumetinib in children with inoperable plexiform neurofibromas
Interview with Brigitte Widemann, MD about Koselugo (selumetinib) the First FDA Approved Drug for NF
Interview with Brigitte Widemann, MD about Koselugo (selumetinib) the First FDA Approved Drug for NF
Believe We Can End NF: Philip Moss 2017
Believe We Can End NF: Philip Moss 2017
GRACEcast-114_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on MEK Inhibitor Selumetinib in NSCLC
GRACEcast-114_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on MEK Inhibitor Selumetinib in NSCLC
Selumetinib in children with inoperable plexiform Neurofibromas
Selumetinib in children with inoperable plexiform Neurofibromas
NF1 With PNs: Future of Treatment With MEK Inhibitors
NF1 With PNs: Future of Treatment With MEK Inhibitors